Social distancing and changes in drug use: Results from a cross-sectional study during the COVID-19 pandemic in Brazil.
SARS-CoV-2 infection
alcohol
anxiety
cannabis
depression
social isolation
substance-related disorders
tobacco
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
07
2022
accepted:
17
10
2022
entrez:
28
11
2022
pubmed:
29
11
2022
medline:
29
11
2022
Statut:
epublish
Résumé
The outbreak of coronavirus disease 19 has led to measures of social distancing and quarantine worldwide. This stressful period may lead to psychological problems, including changes in substance use. In addition, sociodemographic factors are linked to changed levels of drug use and abuse observed during the COVID-19 pandemic, which are also associated with increased anxiety, depression, and other disorders. Thus, the aim of the study was to investigate (i) changes in drug use during the COVID-19 pandemic associated with social distancing, and (ii) to verify factors associated with those changes. A web-based cross-sectional observational survey was completed by a self-selected adult general population in Brazil ( High social distancing was associated with fewer chances (prevalence ratio) of increased drug use for alcohol (0.71, CI Individuals reporting low social distancing increased the use of most drugs during the pandemic, while high social distancing significantly decreased drug use. Anxiety and depressive states and several sociodemographic factors (men; lower income; less education) were associated with higher drug use patterns.
Sections du résumé
Background
UNASSIGNED
The outbreak of coronavirus disease 19 has led to measures of social distancing and quarantine worldwide. This stressful period may lead to psychological problems, including changes in substance use. In addition, sociodemographic factors are linked to changed levels of drug use and abuse observed during the COVID-19 pandemic, which are also associated with increased anxiety, depression, and other disorders. Thus, the aim of the study was to investigate (i) changes in drug use during the COVID-19 pandemic associated with social distancing, and (ii) to verify factors associated with those changes.
Methods
UNASSIGNED
A web-based cross-sectional observational survey was completed by a self-selected adult general population in Brazil (
Results
UNASSIGNED
High social distancing was associated with fewer chances (prevalence ratio) of increased drug use for alcohol (0.71, CI
Conclusions
UNASSIGNED
Individuals reporting low social distancing increased the use of most drugs during the pandemic, while high social distancing significantly decreased drug use. Anxiety and depressive states and several sociodemographic factors (men; lower income; less education) were associated with higher drug use patterns.
Identifiants
pubmed: 36440408
doi: 10.3389/fpsyt.2022.999372
pmc: PMC9682187
doi:
Types de publication
Journal Article
Langues
eng
Pagination
999372Informations de copyright
Copyright © 2022 Nin, Heidrich, Almeida, Izolan, Constant, Freese, Gomez and Barros.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Psychiatry. 2020 Oct 23;11:584462
pubmed: 33192730
Addict Behav. 2021 Jul;118:106879
pubmed: 33706071
Isr J Health Policy Res. 2021 Aug 12;10(1):46
pubmed: 34384483
Addiction. 2008 Jun;103(6):1039-47
pubmed: 18373724
Front Public Health. 2021 Jun 29;9:645376
pubmed: 34268284
J Psychiatr Res. 2021 May;137:96-103
pubmed: 33667763
J Affect Disord. 2014 Feb;155:104-9
pubmed: 24238871
Alcohol Clin Exp Res. 2021 Apr;45(4):802-807
pubmed: 33667019
Am J Drug Alcohol Abuse. 2021 Nov 2;47(6):730-736
pubmed: 34043919
Front Public Health. 2021 Jun 25;9:680028
pubmed: 34249844
Rev Assoc Med Bras (1992). 2004 Apr-Jun;50(2):199-206
pubmed: 15286871
J Public Health (Oxf). 2021 Apr 12;43(1):9-12
pubmed: 33103716
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):817-823
pubmed: 32540735
Front Public Health. 2021 Aug 23;9:709410
pubmed: 34497792
Psychiatry Clin Neurosci. 2020 Oct;74(10):542-549
pubmed: 32602150
Addict Behav. 2021 Mar;114:106754
pubmed: 33310690
Subst Abuse Treat Prev Policy. 2021 Apr 26;16(1):36
pubmed: 33902668
Front Psychiatry. 2020 Dec 21;11:601653
pubmed: 33408655
Front Psychiatry. 2021 Apr 06;12:632519
pubmed: 33889098
J Subst Abuse Treat. 2021 Oct;129:108387
pubmed: 34080555
Front Public Health. 2021 Jul 22;9:656036
pubmed: 34368044
JAMA Netw Open. 2020 Dec 1;3(12):e2027572
pubmed: 33270127
Addiction. 2022 Jan;117(1):182-194
pubmed: 34159666
Int J Environ Res Public Health. 2020 Aug 28;17(17):
pubmed: 32872179
Eur Addict Res. 2020;26(6):309-315
pubmed: 32961535
J Adolesc Health. 2021 Sep;69(3):390-397
pubmed: 34452728
Asian J Psychiatr. 2020 Mar;49:101989
pubmed: 32143142
Viruses. 2021 Oct 31;13(11):
pubmed: 34835002
J Affect Disord. 2022 Jan 1;296:567-576
pubmed: 34600966
Subst Abus. 2020;41(4):409-412
pubmed: 33044893
J Psychiatr Res. 2021 Aug;140:533-544
pubmed: 34174556
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717
J Public Health (Oxf). 2021 Sep 22;43(3):462-465
pubmed: 33367823
BMJ Open. 2021 Mar 15;11(3):e048012
pubmed: 33722876
Int J Environ Res Public Health. 2021 Sep 17;18(18):
pubmed: 34574745
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Environ Res Public Health. 2020 Jun 07;17(11):
pubmed: 32517294
Addiction. 2021 Dec;116(12):3369-3380
pubmed: 34109685
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543
Alcohol Clin Exp Res. 2021 Jul;45(7):1448-1457
pubmed: 34081349
Drug Alcohol Depend. 2021 Sep 1;226:108822
pubmed: 34214884
Front Psychiatry. 2020 Apr 14;11:306
pubmed: 32346373